Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1543b2b19ec0e331a0dcd89888cbef5f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 |
filingDate |
2000-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b5a2caa39ae3c14b7246a3ffc04ed84 |
publicationDate |
2001-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0130316-A2 |
titleOfInvention |
Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime |
abstract |
Systems and devices for the transdermal delivery of the compound (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-one, 0-[3(3-methoxyphenyl)-2-propynyl]oxime are disclosed. These devices include a drug in adhesive reservoir layer and a skin contacting adhesive layer in which the skin contacting adhesive layer acts as a rate controlling membrane. These devices also include a drug in adhesive reservoir layer and a skin contacting adhesive, where a membrane is placed between the two adhesive layers. The compound is a muscarinic agonist, useful in the treatment of a variety of cognitive disorders, including Alzheimer's Disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012012417-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2897598-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1737406-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9017301-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492401-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376473-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10034840-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9205062-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3517105-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9375510-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103068944-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103068944-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198877-B2 |
priorityDate |
1999-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |